The estimated Net Worth of Christopher P. Molineaux is at least $189 Тысяча dollars as of 1 June 2024. Mr. Molineaux owns over 4,660 units of Aclaris Therapeutics Inc stock worth over $62,732 and over the last 9 years he sold ACRS stock worth over $37,996. In addition, he makes $88,085 as Independent Director at Aclaris Therapeutics Inc.
Christopher has made over 10 trades of the Aclaris Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 4,660 units of ACRS stock worth $5,499 on 1 June 2024.
The largest trade he's ever made was exercising 16,500 units of Aclaris Therapeutics Inc stock on 20 June 2023 worth over $23,265. On average, Christopher trades about 3,209 units every 146 days since 2015. As of 1 June 2024 he still owns at least 53,163 units of Aclaris Therapeutics Inc stock.
You can see the complete history of Mr. Molineaux stock trades at the bottom of the page.
Christopher P. Molineaux serves as Independent Director of the Company. Christopher Molineaux has served as a member of our Board since January 2014. Since 2010, Mr. Molineaux has served as President and Chief Executive Officer of Life Sciences Pennsylvania, formerly Pennsylvania Bio, a pharmaceutical and biotech industry advocacy organization, and previously served as its Senior Vice President, Membership Services. Mr. Molineaux previously served as worldwide Vice President of Pharmaceutical Communications and Public Affairs for Johnson & Johnson, a global healthcare company. Mr. Molineaux also served as Vice President for Public Affairs at the Pharmaceutical Research and Manufacturers Association. He received a B.A. degree from the College of the Holy Cross. Our Board believes that Mr. Molineaux’s substantial pharmaceutical and biotechnology industry experience qualifies him to serve as a director of our company.
As the Independent Director of Aclaris Therapeutics Inc, the total compensation of Christopher Molineaux at Aclaris Therapeutics Inc is $88,085. There are 6 executives at Aclaris Therapeutics Inc getting paid more, with Neal Walker having the highest compensation of $3,150,020.
Christopher Molineaux is 54, he's been the Independent Director of Aclaris Therapeutics Inc since 2014. There are 6 older and 6 younger executives at Aclaris Therapeutics Inc. The oldest executive at Aclaris Therapeutics Inc is Maxine Gowen, 62, who is the Independent Director.
Christopher's mailing address filed with the SEC is C/O ACLARIS THERAPEUTICS, INC., 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087.
Over the last 9 years, insiders at Aclaris Therapeutics Inc have traded over $101,608,525 worth of Aclaris Therapeutics Inc stock and bought 10,163,038 units worth $66,383,599 . The most active insiders traders include Braden Michael Leonard, Capital Management, Llc Kol... и Llc Fmr. On average, Aclaris Therapeutics Inc executives and independent directors trade stock every 17 days with the average trade being worth of $111,818. The most recent stock trade was executed by Kevin Balthaser on 1 September 2024, trading 1,000 units of ACRS stock currently worth $1,180.
aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.
Aclaris Therapeutics Inc executives and other stock owners filed with the SEC include: